MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma

Multiple myeloma (MM) remains largely incurable despite significant advances in biotherapy and chemotherapy. The development of drug resistance is a major problem in MM management. Macrophage migration inhibitory factor (MIF) expression was significantly higher in purified MM cells from relapsed pat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood
Asıl Yazarlar: Wang, Qiang, Zhao, Dongyu, Xian, Miao, Wang, Zhuo, Bi, Enguang, Su, Pan, Qian, Jianfei, Ma, Xingzhe, Yang, Maojie, Liu, Lintao, Zu, Youli, Pingali, Sai Ravi, Chen, Kaifu, Cai, Zhen, Yi, Qing
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2020
Konular:
Lymphoid Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7714094/
https://ncbi.nlm.nih.gov/pubmed/32582913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020005795
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller